Boone Capital Management Llc Portfolio Stock Holdings
According to the SEC 13F filed on August 14, 2026, Boone Capital Management Llc disclosed 14 stock positions valued at approximately $427.54M as of quarter-end June 30, 2026. The largest holdings include TELEFLEX INCORPORATED, MIRUM PHARMACEUTICALS INC, and THE CIGNA GROUP.
- Report Period
- June 30, 2026
- No. of Stocks
- 14
- Portfolio Value
- $427.54M
Holdings by Sector
Boone Capital Management Llc Portfolio Holdings in Q2 2026
| Company | Symbol | Sector | Portfolio % | Shares | Change (Shares) | Change % | Value |
|---|---|---|---|---|---|---|---|
| TELEFLEX INCORPORATED | TFX | Healthcare | 11.49% | 387,388 | +108,596 | +38.95% | $49,105,303 |
| MIRUM PHARMACEUTICALS INC | MIRM | Healthcare | 11.38% | 415,641 | -5,595 | -1.33% | $48,659,092 |
| THE CIGNA GROUP | CI | Healthcare | 10.27% | 159,290 | +21,768 | +15.83% | $43,913,067 |
| IONIS PHARMACEUTICALS INC | IONS | Healthcare | 9.64% | 519,977 | +19,455 | +3.89% | $41,228,976 |
| UNITEDHEALTH GROUP INC | UNH | Healthcare | 8.62% | 88,687 | +9,461 | +11.94% | $36,860,978 |
| BIOMARIN PHARMACEUTICAL INC | BMRN | Healthcare | 7.81% | 583,219 | +35,348 | +6.45% | $33,371,791 |
| VESTIS CORPORATION | VSTS | Industrials | 6.45% | 1,900,140 | +1,900,140 | +100.00% | $27,590,033 |
| BRIDGEBIO PHARMA INC | BBIO | Healthcare | 5.92% | 339,720 | +110,891 | +48.46% | $25,302,346 |
| PENNANT GROUP INC | PNTG | Healthcare | 4.46% | 515,818 | +515,818 | +100.00% | $19,059,475 |
| MONTE ROSA THERAPEUTICS INC | GLUE | Healthcare | 3.48% | 615,287 | +615,287 | +100.00% | $14,889,945 |
| KODIAK SCIENCES INC | KOD | Healthcare | 3.44% | 378,010 | +96,678 | +34.36% | $14,727,270 |
| TANGO THERAPEUTICS INC | TNGX | Healthcare | 3.33% | 455,605 | +455,605 | +100.00% | $14,242,212 |
| KYMERA THERAPEUTICS INC | KYMR | Healthcare | 3.04% | 113,173 | +113,173 | +100.00% | $12,977,548 |
| CULLINAN THERAPEUTICS INC | CGEM | Healthcare | 3.00% | 704,442 | +704,442 | +100.00% | $12,827,889 |
Showing 14 of 14 holdings in the latest reporting period.